---
figid: PMC9368983__ijms-23-08281-g002
figtitle: 'Actions of Metformin in the Brain: A New Perspective of Metformin Treatments
  in Related Neurological Disorders'
organisms:
- Nicotiana tabacum
- Syringa vulgaris
- Galega officinalis
- Dendrobium nobile
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
- Caenorhabditis elegans
- Homo sapiens
- prion
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC9368983
filename: ijms-23-08281-g002.jpg
figlink: /pmc/articles/PMC9368983/figure/ijms-23-08281-f002/
number: F2
caption: Potential mechanisms underlying the actions of metformin in the brain. In
  neurons, metformin regulates autophagy by AMPK/mTORC1 signaling pathway to alleviate
  abnormal protein aggregation. In addition, metformin decreases oxidative stress
  by regulating mitochondrial homeostasis. In astrocytes, metformin suppresses neuroinflammation
  by inhibiting reactive astrocyte proliferation and proinflammatory factors. In synaptic
  transmission, metformin may regulate E/I balance by directly regulating the amount
  of presynaptic neurotransmitter release or altering the expression level of receptors
  on the postsynaptic membrane. Metformin significantly ameliorates synaptic morphological
  defects and enhances synaptic plasticity in a variety of pathological conditions.
  AMPK, 5’-AMP-activated protein kinase; mTORC1, mechanistic target of rapamycin complex
  1; AMPAR, AMPA-type glutamate receptor; NMDAR, NMDA receptors; PSD-95, postsynaptic
  density protein 95; BDNF, brain-derived neurotrophic factor; FoxO3a, forkhead box
  O3a; GABA, gamma-aminobutyric acid; GABAAR, GABA type A receptor.
papertitle: 'Actions of Metformin in the Brain: A New Perspective of Metformin Treatments
  in Related Neurological Disorders.'
reftext: Nuojin Li, et al. Int J Mol Sci. 2022 Aug;23(15):8281.
year: '2022'
doi: 10.3390/ijms23158281
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: metformin | synapse | synaptic transmission | neurological disorders
automl_pathway: 0.9498245
figid_alias: PMC9368983__F2
figtype: Figure
redirect_from: /figures/PMC9368983__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9368983__ijms-23-08281-g002.html
  '@type': Dataset
  description: Potential mechanisms underlying the actions of metformin in the brain.
    In neurons, metformin regulates autophagy by AMPK/mTORC1 signaling pathway to
    alleviate abnormal protein aggregation. In addition, metformin decreases oxidative
    stress by regulating mitochondrial homeostasis. In astrocytes, metformin suppresses
    neuroinflammation by inhibiting reactive astrocyte proliferation and proinflammatory
    factors. In synaptic transmission, metformin may regulate E/I balance by directly
    regulating the amount of presynaptic neurotransmitter release or altering the
    expression level of receptors on the postsynaptic membrane. Metformin significantly
    ameliorates synaptic morphological defects and enhances synaptic plasticity in
    a variety of pathological conditions. AMPK, 5’-AMP-activated protein kinase; mTORC1,
    mechanistic target of rapamycin complex 1; AMPAR, AMPA-type glutamate receptor;
    NMDAR, NMDA receptors; PSD-95, postsynaptic density protein 95; BDNF, brain-derived
    neurotrophic factor; FoxO3a, forkhead box O3a; GABA, gamma-aminobutyric acid;
    GABAAR, GABA type A receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - GRIN1
  - GRIN2A
  - GRIN2B
  - GRIN2C
  - GRIN2D
  - GRIN3A
  - GRIN3B
  - PLXNA2
  - BDNF
  - BDNF-AS
  - FOXO3
  - SNF4Agamma
  - AMPKalpha
  - Nmdar2
  - Nmdar1
  - Rdl
  - Crtc
  - GABA-B-R1
  - Gabat
---
